A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019

医学 入射(几何) 人口学 相对存活率 置信区间 民族 相对风险 生存分析 癌症 内科学 老年学 癌症登记处 物理 社会学 人类学 光学
作者
Kevin Campbell,David A. Siegel,Puja J. Umaretiya,Shifan Dai,Andras Heczey,Philip J. Lupo,Jeremy M. Schraw,Trevor Thompson,Michael E. Scheurer,Jennifer H. Foster
出处
期刊:Pediatric Blood & Cancer [Wiley]
卷期号:71 (1) 被引量:8
标识
DOI:10.1002/pbc.30732
摘要

Abstract Background We characterize the incidence and 5‐year survival of children and adolescents with neuroblastoma stratified by demographic and clinical factors based on the comprehensive data from United States Cancer Statistics (USCS) and the National Program of Cancer Registries (NPCR). Methods We analyzed the incidence of neuroblastoma from USCS (2003–2019) and survival data from NPCR (2001–2018) for patients less than 20 years old. Incidence trends were calculated by average annual percent change (AAPC) using joinpoint regression. Differences in relative survival were estimated comparing non‐overlapping confidence intervals (CI). Results We identified 11,543 primary neuroblastoma cases in USCS. Age‐adjusted incidence was 8.3 per million persons [95% CI: 8.2, 8.5], with an AAPC of 0.4% [95% CI: −0.1, 0.9]. Five‐year relative survival from the NPCR dataset ( n = 10,676) was 79.7% [95% CI: 78.9, 80.5]. Patients aged less than 1 year had the highest 5‐year relative survival (92.5%). Five‐year relative survival was higher for non‐Hispanic White patients (80.7%) or Hispanic patients (80.8%) compared to non‐Hispanic Black patients (72.6%). Conclusion Neuroblastoma incidence was stable during 2003–2019. Differences in relative survival exist by sex, age, race/ethnicity, and stage; patients who were male, older, non‐Hispanic Black, or with distant disease had worse survival. Future studies could seek to assess the upstream factors driving disparities in survival, and evaluate interventions to address inequities and improve survival across all groups.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
Stroeve发布了新的文献求助10
3秒前
欧阳月空完成签到,获得积分10
3秒前
3秒前
星辰大海应助李小宁采纳,获得10
4秒前
段一帆发布了新的文献求助10
4秒前
冷艳的姿发布了新的文献求助10
4秒前
5秒前
FIN应助小小采纳,获得30
5秒前
领导范儿应助su采纳,获得10
6秒前
Candy发布了新的文献求助10
6秒前
Rondab应助xiaosu采纳,获得10
7秒前
CodeCraft应助LJJ采纳,获得10
8秒前
8秒前
SYLH应助科研通管家采纳,获得20
9秒前
所所应助科研通管家采纳,获得10
9秒前
科研通AI5应助科研通管家采纳,获得10
9秒前
张金蝶完成签到,获得积分10
9秒前
搜集达人应助科研通管家采纳,获得10
10秒前
CAOHOU应助科研通管家采纳,获得10
10秒前
丘比特应助科研通管家采纳,获得10
10秒前
CAOHOU应助科研通管家采纳,获得10
10秒前
赘婿应助科研通管家采纳,获得10
10秒前
量子星尘发布了新的文献求助30
10秒前
SYLH应助科研通管家采纳,获得20
10秒前
10秒前
10秒前
10秒前
CAOHOU应助科研通管家采纳,获得10
10秒前
Lyuhng+1完成签到 ,获得积分10
11秒前
大个应助十九岁的时差采纳,获得10
12秒前
15秒前
桃花落完成签到,获得积分10
18秒前
su发布了新的文献求助10
18秒前
思源应助汪汪采纳,获得10
18秒前
高兴的天蓝完成签到 ,获得积分10
19秒前
19秒前
20秒前
星星应助momo采纳,获得10
20秒前
21秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989334
求助须知:如何正确求助?哪些是违规求助? 3531428
关于积分的说明 11253936
捐赠科研通 3270119
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173